San Diego, CA, United States of America

Alexander Russell Abela

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 22.6

ph-index = 6

Forward Citations = 72(Granted Patents)


Location History:

  • San Diego, CA (US) (2020 - 2022)
  • Escondido, CA (US) (2021 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Alexander Russell Abela

Introduction

Alexander Russell Abela is an accomplished inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceutical research. With a total of seven patents to his name, Abela's work primarily focuses on developing innovative treatments and compositions for medical applications, particularly in relation to cystic fibrosis.

Latest Patents

Abela’s most recent patents revolve around modulators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). His latest innovations involve pharmaceutical compositions, methods of treatment, and processes for creating these modulators. Specifically, the patents detail compounds of Formula (I), including pharmaceutically acceptable salts, deuterated derivatives, and metabolites of these compounds. He has disclosed methods for treating cystic fibrosis using these novel compositions and provided the means for their production. Additionally, solid-state forms of the discussed compounds, along with their salts and solvates, have also been covered in his latest patents. These advancements reflect Abela's dedication to improving therapeutic options for individuals suffering from cystic fibrosis.

Career Highlights

Currently, Alexander Russell Abela is a prominent member of Vertex Pharmaceuticals, Inc., where he leverages his expertise in pharmacology and drug development to drive innovation. His career is marked by a commitment to enhancing patient outcomes through research and development initiatives focused on complex genetic disorders.

Collaborations

Abela collaborates closely with talented coworkers, including Sara Sabina Hadida Ruah and Jason McCartney. These partnerships highlight the collaborative nature of pharmaceutical innovation, where diverse expertise is essential for tackling challenging medical issues. Together, they aim to pioneer advancements that significantly benefit patients and the medical community at large.

Conclusion

In conclusion, Alexander Russell Abela stands as a noteworthy inventor in the realm of pharmaceutical sciences, specifically targeting cystic fibrosis. With a strong portfolio of patents and a collaborative approach in his career, Abela continues to contribute meaningfully to the field, offering hope through innovative treatments and compositions. His work embodies the spirit of innovation that drives advancements in medicine and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…